12790 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA
Market cap: $1.0B (2/08/2026)
Price: $13.95
2026 Cash Bonus Awards Granted to Key Executives at Ventyx Biosciences
To acquire to advance oral therapies targeting inflammatory-mediated diseases
Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Investor Presentation
Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
Shareholder votes
Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Merger Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
PREM14A